Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.
Brück K, Meijer RP, Boormans JL, Kiemeney LA, Witjes JA, van Hoogstraten LMC, van der Heijden MS, Donders AR, Franckena M, Uyl de Groot CA, Leliveld AM, Aben KKH, Hulshof MCCM. Brück K, et al. Among authors: uyl de groot ca. Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):41-49. doi: 10.1016/j.ijrobp.2023.07.027. Epub 2023 Jul 28. Int J Radiat Oncol Biol Phys. 2024. PMID: 37517601
Individualized positron emission tomography-based isotoxic accelerated radiation therapy is cost-effective compared with conventional radiation therapy: a model-based evaluation.
Bongers ML, Coupé VM, De Ruysscher D, Oberije C, Lambin P, Uyl-de Groot CA. Bongers ML, et al. Among authors: uyl de groot ca, de ruysscher d. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):857-65. doi: 10.1016/j.ijrobp.2014.12.012. Int J Radiat Oncol Biol Phys. 2015. PMID: 25752401
Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.
De Groot S, Blommestein HM, Redekop WK, Sleijfer S, Kiemeney LALM, Oosterwijk E, Uyl-de Groot CA. De Groot S, et al. Among authors: uyl de groot ca. PLoS One. 2017 May 22;12(5):e0177364. doi: 10.1371/journal.pone.0177364. eCollection 2017. PLoS One. 2017. PMID: 28531203 Free PMC article.
Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry.
Notohardjo JCL, Kuppen MCP, Westgeest HM, van Moorselaar RJA, Mehra N, Coenen JLLM, van Oort IM, de Vos AI, Vervenne WL, van den Bergh ACM, Aben KKH, Somford DM, Bergman AM, Uyl-de Groot CA, Gerritsen WR, van den Eertwegh AJM. Notohardjo JCL, et al. Among authors: uyl de groot ca, de vos ai. Eur Urol Focus. 2021 Jul;7(4):788-796. doi: 10.1016/j.euf.2020.03.009. Epub 2020 Apr 30. Eur Urol Focus. 2021. PMID: 32362484
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer.
Kuppen MC, Westgeest HM, van der Doelen MJ, van den Eertwegh AJ, Coenen JL, Aben KK, van den Bergh AC, Bergman AM, den Bosch JV, Celik F, Hendriks MP, Lavalaye J, der Meer SV, Polee MB, Somford DM, van Oort IM, Uyl-de Groot CA, Gerritsen WR. Kuppen MC, et al. Among authors: uyl de groot ca. Future Oncol. 2020 Jul;16(19):1371-1384. doi: 10.2217/fon-2020-0039. Epub 2020 May 29. Future Oncol. 2020. PMID: 32469606
250 results